You are currently viewing a new version of our website. To view the old version click .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Review
  • Open Access

13 April 2007

The Epidemiology of Lung Cancer

and
Katedra i Klinika Pulmonologii i Nowotworów Płuc Akademii Medycznej we Wrocławiu, ul. Grabiszyńska 105, 53-439 Wrocław, Poland
*
Author to whom correspondence should be addressed.

Abstract

Lung cancer is currently most frequently diagnosed neoplasm in males and the fifth most frequent cancer in females. In developed countries only breast cancer is diagnosed more often in women. Worldwide, lung cancer is the most common cause of cancer mortality in males and females. In the Europe lung cancer accounts for 21% of all cancer cases in males and 29% of all cancer deaths. The rapid increase in lung cancer incidence was observed the since beginning of the XX century till 1990–1994. The incidence in males decreased recently, but still increases in females, especially in young women. The changes in frequency of various histological subtypes of lung cancer are observed too. Despite many clinical trials, modern diagnostic techniques and improved supportive care, the prognosis remains unfavourable and long-term survival almost did not change. In Poland the incidence of lung cancer in 2002 was 81.9/100,000 in males and 22.2/100,000 in females. In both genders 1-year and 5-year survivals time are one of the shortest in Europe.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.